论文部分内容阅读
日前,烟台市科技局组织专家对山东京蓬生物药业股份有限公司承担的国际合作项目“噻虫胺原药”进行了鉴定。专家组一致认为,“噻虫胺原药”项目不仅环保低毒,而且使用成本低,符合中国农作物种植的国情,其整体技术达到国际先进水平。并且该项目已按合同要求完成了全部研究和试验工作,经费使用合理,同意该项目通过鉴定及验收。据了解,“噻虫胺原药”项目是由京蓬生物药业和日本住友化学株式会社共同研究开发,采用自制催化剂,以硝基胍、一甲胺等为原料,经过缩合、水解制成,收率达到85%以上,纯度达到98%,产品质量稳定。京蓬生物药业为解决噻虫胺原药现有的四种制备
Recently, Yantai Science and Technology Bureau organized experts to carry out the appraisal on the international cooperation project “Clothianidin” undertaken by Shandong Jing Peng Biological Medicine Co., Ltd. The panel agreed that the “clothianidin original drug” project is not only environmentally friendly and has low toxicity, but also has low cost of use and is in line with the actual conditions of crop planting in China. Its overall technology has reached the international advanced level. And the project has completed all the research and experimental work as required by the contract. The funds are used reasonably and the project has passed the appraisal and acceptance. It is understood that “clothianidin original drug ” project is a joint research and development by the Beijing Punta biological medicine and Japan Sumitomo Chemical Co., Ltd., using self-made catalyst to nitroguanidine, monomethylamine and other raw materials, after condensation, hydrolysis Made in more than 85% yield, purity of 98%, product quality and stability. Jing Peng biological medicine to solve the original preparation of clothianidin four drugs